The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells
- PMID: 25652040
- PMCID: PMC4459022
- DOI: 10.1111/bph.13107
The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells
Abstract
Background and purpose: Lysophosphatidylinositol (LPI), a lipid signalling molecule, activates GPR55 and elevates intracellular Ca(2+). Here, we examine the actions of LPI in the rat resistance mesenteric artery and Ca(2+) responses in endothelial cells isolated from the artery.
Experimental approach: Vascular responses were studied using wire myographs. Single-cell fluorescence imaging was performed using a MetaFluor system. Hypotensive effects of LPI were assessed using a Biopac system.
Key results: In isolated arteries, LPI-induced vasorelaxation was concentration- and endothelium-dependent and inhibited by CID 16020046, a GPR55 antagonist. The CB1 receptor antagonist AM 251 had no effect, whereas rimonabant and O-1918 significantly potentiated LPI responses. Vasorelaxation was reduced by charybdotoxin and iberiotoxin, alone or combined. LPI decreased systemic arterial pressure. GPR55 is expressed in rat mesenteric artery. LPI caused biphasic elevations of endothelial cell intracellular Ca(2+). Pretreatment with thapsigargin or 2-aminoethoxydiphenyl borate abolished both phases. The PLC inhibitor U73122 attenuated the initial phase and enhanced the second phase, whereas the Rho-associated kinase inhibitor Y-27632 abolished the late phase but not the early phase.
Conclusions and implications: LPI is an endothelium-dependent vasodilator in the rat small mesenteric artery and a hypotensive agent. The vascular response involves activation of Ca(2+)-sensitive K(+) channels and is not mediated by CB1 receptors, but unexpectedly enhanced by antagonists of the 'endothelial anandamide' receptor. In endothelial cells, LPI utilizes PLC-IP3 and perhaps ROCK-RhoA pathways to elevate intracellular Ca(2+). Overall, these findings support an endothelial site of action for LPI and suggest a possible role for GPR55 in vasculature.
© 2015 The British Pharmacological Society.
Figures








Similar articles
-
GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier.Neuroscience. 2019 Aug 21;414:88-98. doi: 10.1016/j.neuroscience.2019.06.039. Epub 2019 Jul 4. Neuroscience. 2019. PMID: 31279825 Free PMC article.
-
GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.Br J Pharmacol. 2010 Sep;161(2):308-20. doi: 10.1111/j.1476-5381.2010.00744.x. Br J Pharmacol. 2010. PMID: 20735417 Free PMC article.
-
Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery.Eur J Pharmacol. 2013 Feb 28;702(1-3):1-11. doi: 10.1016/j.ejphar.2013.01.006. Epub 2013 Jan 20. Eur J Pharmacol. 2013. PMID: 23340219
-
The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.Prostaglandins Other Lipid Mediat. 2013 Dec;107:103-16. doi: 10.1016/j.prostaglandins.2013.05.004. Epub 2013 May 25. Prostaglandins Other Lipid Mediat. 2013. PMID: 23714700 Review.
-
GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?Curr Top Med Chem. 2010;10(8):799-813. doi: 10.2174/156802610791164229. Curr Top Med Chem. 2010. PMID: 20370712 Review.
Cited by
-
Elucidation of GPR55-Associated Signaling behind THC and LPI Reducing Effects on Ki67-Immunoreactive Nuclei in Patient-Derived Glioblastoma Cells.Cells. 2023 Nov 17;12(22):2646. doi: 10.3390/cells12222646. Cells. 2023. PMID: 37998380 Free PMC article.
-
GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier.Neuroscience. 2019 Aug 21;414:88-98. doi: 10.1016/j.neuroscience.2019.06.039. Epub 2019 Jul 4. Neuroscience. 2019. PMID: 31279825 Free PMC article.
-
Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning.Cell Commun Signal. 2021 Apr 26;19(1):48. doi: 10.1186/s12964-021-00727-w. Cell Commun Signal. 2021. PMID: 33902596 Free PMC article.
-
Preclinical safety and efficacy of cannabidivarin for early life seizures.Neuropharmacology. 2019 Apr;148:189-198. doi: 10.1016/j.neuropharm.2019.01.002. Epub 2019 Jan 10. Neuropharmacology. 2019. PMID: 30633929 Free PMC article.
-
l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway.Pharmacol Res Perspect. 2019 May 24;7(3):e00487. doi: 10.1002/prp2.487. eCollection 2019 Jun. Pharmacol Res Perspect. 2019. PMID: 31149342 Free PMC article.
References
-
- AlSuleimani YM. 2011. PhD thesis, University of Cambridge, Cambridge, UK An investigation into the actions of novel lipid signalling molecules in the vasculature.
-
- AlSuleimani YM, Hiley CR. Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery. Eur J Pharmacol. 2013;702:1–11. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous